George Geromichalos

Summary

Affiliation: Aristotle University of Thessaloniki
Country: Greece

Publications

  1. ncbi Significant experimental decrease of the hepatocellular carcinoma incidence in C3H/Sy mice after long-term administration of EB1089, a vitamin D analogue
    Despina Sahpazidou
    Symeonides Research Center, Theagenio Cancer Hospital, Thessaloniki, Greece
    Oncol Res 13:261-8. 2003
  2. ncbi Synergistic interaction between a mixed ligand copper (II) chelate complex and two anticancer agents in T47D human breast cancer cells in vitro
    G D Geromichalos
    Laboratory of Cell Culture Molecular Modeling and Drug Design, Symeonidio Research Center, Theagenio Cancer Hospital, Thessaloniki, Greece
    J BUON 11:469-76. 2006
  3. ncbi NSC 290205-based therapy in murine pancreatic adenocarcinoma PAN02 in combination with adriamycin (ADR)
    Athanasios Papageorgiou
    Department of Experimental Chemotherapy, Symeonidion Research Center, Thessaloniki, Greece
    Anticancer Res 26:243-7. 2006
  4. ncbi Antitumour and cytogenetic effects of modified steroidal derivatives of propenoic acid: in vivo/in vitro studies
    Athanasios Papageorgiou
    Symeonidion Research Center, Theagenion Cancer Hospital, Thessaloniki, Greece
    Anticancer Res 30:4201-4. 2010
  5. ncbi In vitro evaluation of the cytotoxicity of ProRoot MTA and MTA Angelus
    Elisabeth A Koulaouzidou
    Department of Operative Dentistry, Faculty of Dentistry, Aristotle University of Thessaloniki, Thessaloniki, Greece
    J Oral Sci 50:397-402. 2008
  6. ncbi Cytogenetic and antineoplastic effects of modified steroidal alkylators
    Irini Karapidaki
    Laboratory of Biology and Genetics, Medical School, Aristotle University of Thessaloniki, Thessaloniki, Greece
    Genet Test Mol Biomarkers 14:93-7. 2010
  7. ncbi Diorganotin(IV) complexes of dipeptides containing the alpha-aminoisobutyryl residue (Aib): preparation, structural characterization, antibacterial and antiproliferative activities of [(n-Bu)2 Sn(H(-1)L)] (LH=H-Aib-L-Leu-OH, H-Aib-L-Ala-OH)
    Eugenia Katsoulakou
    Department of Chemistry, University of Patras, 265 04 Patras, Greece
    J Inorg Biochem 102:1397-405. 2008

Collaborators

  • Athanasios Papageorgiou
  • Charalambos Andreadis
  • Irini Karapidaki
  • Elisabeth A Koulaouzidou
  • Eugenia Katsoulakou
  • Konstantinos Papazisis
  • Despina Sahpazidou
  • George Pairas
  • Denis Mourelatos
  • Theodoros Lialiaris
  • Ioanna Papaconstadinou
  • Anna Koutsourea
  • Sotiris Nikolaropoulos
  • Manolis Fousteris
  • Catherine Raptopoulou
  • Rigini Papi
  • Paul Cordopatis
  • Anastasia Pantazaki
  • Evy Manessi-Zoupa
  • Manolis Tiliakos
  • Giannis Papaefstathiou
  • Panagiotis Beltes
  • Dimitris Kyriakidis
  • Nikolaos Economides
  • Aris Terzis
  • George Zafiriou
  • Theano Toliou
  • Panagiotis Gigis
  • Pelagia Stravoravdi
  • Konstantinos Natsis

Detail Information

Publications7

  1. ncbi Significant experimental decrease of the hepatocellular carcinoma incidence in C3H/Sy mice after long-term administration of EB1089, a vitamin D analogue
    Despina Sahpazidou
    Symeonides Research Center, Theagenio Cancer Hospital, Thessaloniki, Greece
    Oncol Res 13:261-8. 2003
    ..0001) inhibitory effect on HCC incidence of C3H/Sy mice. This effect could be useful in a potential application on the chemopreventive control of HCCs...
  2. ncbi Synergistic interaction between a mixed ligand copper (II) chelate complex and two anticancer agents in T47D human breast cancer cells in vitro
    G D Geromichalos
    Laboratory of Cell Culture Molecular Modeling and Drug Design, Symeonidio Research Center, Theagenio Cancer Hospital, Thessaloniki, Greece
    J BUON 11:469-76. 2006
    ..Previous theoretical quantum-chemical studies of this complex and ass adducts with biological molecules elucidated the underlying mechanism of action of this complex...
  3. ncbi NSC 290205-based therapy in murine pancreatic adenocarcinoma PAN02 in combination with adriamycin (ADR)
    Athanasios Papageorgiou
    Department of Experimental Chemotherapy, Symeonidion Research Center, Thessaloniki, Greece
    Anticancer Res 26:243-7. 2006
    ..In this study, the antitumor activity of A in combination with ADR (AHOP) was investigated in comparison with the standard CHOP regimen...
  4. ncbi Antitumour and cytogenetic effects of modified steroidal derivatives of propenoic acid: in vivo/in vitro studies
    Athanasios Papageorgiou
    Symeonidion Research Center, Theagenion Cancer Hospital, Thessaloniki, Greece
    Anticancer Res 30:4201-4. 2010
    ....
  5. ncbi In vitro evaluation of the cytotoxicity of ProRoot MTA and MTA Angelus
    Elisabeth A Koulaouzidou
    Department of Operative Dentistry, Faculty of Dentistry, Aristotle University of Thessaloniki, Thessaloniki, Greece
    J Oral Sci 50:397-402. 2008
    ..Both MTA materials tested exerted mild suppression of cellular mitochondrial activity and may be characterized as biologically inert materials...
  6. ncbi Cytogenetic and antineoplastic effects of modified steroidal alkylators
    Irini Karapidaki
    Laboratory of Biology and Genetics, Medical School, Aristotle University of Thessaloniki, Thessaloniki, Greece
    Genet Test Mol Biomarkers 14:93-7. 2010
    ..The steroidal part is aimed to act as a biological platform enabling the alkylating moiety to approach its site of action by altering its physicochemical properties...
  7. ncbi Diorganotin(IV) complexes of dipeptides containing the alpha-aminoisobutyryl residue (Aib): preparation, structural characterization, antibacterial and antiproliferative activities of [(n-Bu)2 Sn(H(-1)L)] (LH=H-Aib-L-Leu-OH, H-Aib-L-Ala-OH)
    Eugenia Katsoulakou
    Department of Chemistry, University of Patras, 265 04 Patras, Greece
    J Inorg Biochem 102:1397-405. 2008
    ..Complexes 1 and 2 are active against the gram-positive bacteria Bacillus subtilis and Bacillus cereus. The IC(50) values reveal that the two compounds express promising cytotoxic activity in vitro against a series of cell lines...